AETHLON MEDICAL INC (AEMD)
NASDAQHealth CareMedical - DevicesSnapshot 2026-09-04
$1.82-5.70%
Close 2026-09-04 · 1-day change
NASDAQHealth CareMedical - DevicesSnapshot 2026-09-04
QuarterlyIQ Insights · AEMD
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of None, except per-share and ratios.
| TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2012 | Mar 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | |||||||||||||||
| Revenues | — | — | — | — | 0.6 | 0.3 | 0.7 | 0.7 | 0.2 | 0.4 | 0.9 | 0.8 | 1.6 | 1.2 | 1.4 |
| Total Revenues | — | — | — | — | 0.6 | 0.3 | 0.7 | 0.7 | 0.2 | 0.4 | 0.9 | 0.8 | 1.6 | 1.2 | 1.4 |
| Operating Expenses & Income | |||||||||||||||
| R&D Expenses | 1.9 | 1.9 | 2.2 | 2.5 | 2.7 | 2.3 | 2.1 | 0.9 | 0.9 | 0.7 | 0.8 | 1.0 | 1.5 | — | — |
| Operating Income | (7.1) | (7.3) | (9.3) | (12.6) | (11.9) | (10.4) | (7.9) | (5.9) | (6.0) | (6.1) | (4.4) | (4.0) | (3.1) | (3.6) | (3.1) |
| Earnings from Continuing Operations | |||||||||||||||
| Interest Expense | — | 0.0 | 0.0 | — | — | — | — | — | — | — | — | 0.3 | — | — | — |
| Interest & Investment Income | — | 0.2 | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Other Non-Operating Income / Expenses | — | 0.1 | — | — | — | — | (0.0) | (0.5) | — | — | — | — | 10.4 | 1.3 | 5.0 |
| Asset Writedown | — | — | — | — | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | — | — |
| EBT, Incl. Unusual Items | — | (7.2) | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Income Tax Expense | — | — | — | — | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | — |
| Net Income | |||||||||||||||
| Minority Interest | — | — | — | — | 0.0 | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.1) | (0.2) | (0.1) | — | — |
| Net Income | (6.9) | (7.2) | (13.4) | (12.2) | (12.0) | (10.4) | (7.9) | (6.4) | (6.2) | (7.3) | (4.9) | (6.8) | (13.4) | (4.9) | (8.1) |
| Per Share | |||||||||||||||
| Basic EPS | (18.03) | (10.61) | (8.58) | (4.86) | (5.86) | (0.71) | — | — | — | — | — | — | — | — | — |
| Diluted EPS | (18.03) | (10.61) | (8.58) | (4.86) | (5.86) | (0.71) | — | — | — | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 0.4 | 0.7 | 1.6 | 2.5 | 2.1 | 14.8 | — | — | — | — | — | — | 194.1 | 149.2 | — |
| Diluted Weighted Avg Shares | 0.4 | 0.7 | 1.6 | 2.5 | 2.1 | 14.8 | — | — | — | — | — | — | — | — | — |
| Supplemental | |||||||||||||||
| EBITDA | — | (7.0) | (9.0) | (12.3) | (11.7) | (10.3) | (7.9) | (5.9) | (6.0) | (6.1) | (4.3) | (4.0) | (3.0) | (3.6) | (3.1) |
| EBIT | (7.1) | (7.3) | (9.3) | (12.6) | (11.9) | (10.4) | (7.9) | (5.9) | (6.0) | (6.1) | (4.4) | (4.0) | (3.1) | (3.6) | (3.1) |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.